Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Tempest Therapeutics Q4 EPS $(0.63) Beats $(0.76) Estimate

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share
byHappy Mohamed
March 23, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: SAP Q2 Earnings

By Benzinga Insights
July 21, 4:43 AM
  SAP (NYSE:SAP) reported its Q2 earnings results on Thursday, July 21, 2022 at 01:00 AM. Here's what investors need to know about the announcement. Earnings SAP missed estimated earnings by 11.3%, reporting an EPS of $1.02 versus an estimate of $1.15.

SAP

Read More

Retractable Technologies And 3 Other Stocks Under $3 Insiders Are Buying

By Avi Kapoor
January 5, 7:55 AM
The Dow Jones index closed higher by around 10 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CDZI